Perfil
Julianna R.
Wood worked as a Senior Director of Investor Relations at Chiron Corp.
She then worked as a Senior Director of Investor Relations at Sangamo Therapeutics, Inc. from 2000 to 2001, and at Caliper Technologies Corp.
from 2001 to 2003.
From 2003 to 2011, she worked as the VP of Corporate Communications and Investor Relations at Onyx Pharmaceuticals, Inc. She then worked as the SVP of Investor Relations and Corporate Communications at Adamas Pharmaceuticals LLC.
Ms. Wood received her undergraduate degree from Stanford University and her MBA from The Fuqua School of Business.
Antiguos cargos conocidos de Julianna R. Wood.
| Empresas | Cargo | Fin |
|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | - |
Caliper Technologies Corp.
 Caliper Technologies Corp. Medical SpecialtiesHealth Technology Caliper Technologies Corp. is a private company that provides microfluidic technology and laboratory automation solutions to the life science, biotechnology, and pharmaceutical industries worldwide. The company is based in Mountain View, CA. The company was founded by J. Michael Ramsey. | Public Communications Contact | 01/05/2003 |
| SANGAMO THERAPEUTICS, INC. | Public Communications Contact | 01/08/2001 |
| ADAMAS PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Public Communications Contact | - |
Formación de Julianna R. Wood.
| Stanford University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Caliper Technologies Corp.
Caliper Technologies Corp. Medical SpecialtiesHealth Technology Caliper Technologies Corp. is a private company that provides microfluidic technology and laboratory automation solutions to the life science, biotechnology, and pharmaceutical industries worldwide. The company is based in Mountain View, CA. The company was founded by J. Michael Ramsey. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Julianna R. Wood
